203 related articles for article (PubMed ID: 2983428)
21. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
[TBL] [Abstract][Full Text] [Related]
22. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.
Mishkin EM; Fahey JR; Kino Y; Klein RJ; Abramovitz AS; Mento SJ
Vaccine; 1991 Mar; 9(3):147-53. PubMed ID: 1645898
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.
Hazama M; Mayumi-Aono A; Asakawa N; Kuroda S; Hinuma S; Fujisawa Y
Vaccine; 1993; 11(6):629-36. PubMed ID: 8391739
[TBL] [Abstract][Full Text] [Related]
24. A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection.
Hook LM; Awasthi S; Dubin J; Flechtner J; Long D; Friedman HM
Vaccine; 2019 Jan; 37(4):664-669. PubMed ID: 30551986
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
Bernstein DI; Miller RL; Harrison CJ
J Infect Dis; 1993 Mar; 167(3):731-5. PubMed ID: 8382722
[TBL] [Abstract][Full Text] [Related]
26. DNA immunization against experimental genital herpes simplex virus infection.
Bourne N; Stanberry LR; Bernstein DI; Lew D
J Infect Dis; 1996 Apr; 173(4):800-7. PubMed ID: 8603957
[TBL] [Abstract][Full Text] [Related]
27. The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs.
Bernstein DI; Farley N; Bravo FJ; Earwood J; McNeal M; Fairman J; Cardin R
Vaccine; 2010 May; 28(21):3748-53. PubMed ID: 19857450
[TBL] [Abstract][Full Text] [Related]
28. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
Aurelian L; Smith CC; Wachsman M; Paoletti E
Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
[TBL] [Abstract][Full Text] [Related]
29. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.
Boursnell ME; Entwisle C; Blakeley D; Roberts C; Duncan IA; Chisholm SE; Martin GM; Jennings R; Ni Challanaín D; Sobek I; Inglis SC; McLean CS
J Infect Dis; 1997 Jan; 175(1):16-25. PubMed ID: 8985191
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
[TBL] [Abstract][Full Text] [Related]
31. Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.
Awasthi S; Balliet JW; Flynn JA; Lubinski JM; Shaw CE; DiStefano DJ; Cai M; Brown M; Smith JF; Kowalski R; Swoyer R; Galli J; Copeland V; Rios S; Davidson RC; Salnikova M; Kingsley S; Bryan J; Casimiro DR; Friedman HM
J Virol; 2014 Feb; 88(4):2000-10. PubMed ID: 24284325
[TBL] [Abstract][Full Text] [Related]
32. Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection.
Bernstein DI
Vaccine; 2000 Jan; 18(14):1351-8. PubMed ID: 10618532
[TBL] [Abstract][Full Text] [Related]
33. Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.
McLean CS; Erturk M; Jennings R; Challanain DN; Minson AC; Duncan I; Boursnell ME; Inglis SC
J Infect Dis; 1994 Nov; 170(5):1100-9. PubMed ID: 7963701
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of a herpes simplex subunit vaccine.
Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
[TBL] [Abstract][Full Text] [Related]
35. An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.
Skoberne M; Cardin R; Lee A; Kazimirova A; Zielinski V; Garvie D; Lundberg A; Larson S; Bravo FJ; Bernstein DI; Flechtner JB; Long D
J Virol; 2013 Apr; 87(7):3930-42. PubMed ID: 23365421
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection.
Egan K; Hook LM; Naughton A; Friedman HM; Awasthi S
Hum Vaccin Immunother; 2020 Sep; 16(9):2109-2113. PubMed ID: 32347775
[TBL] [Abstract][Full Text] [Related]
38. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
Bourne N; Milligan GN; Stanberry LR; Stegall R; Pyles RB
J Infect Dis; 2005 Dec; 192(12):2117-23. PubMed ID: 16288376
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE
J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
